Skip to content

Nuvalent, Inc. NUVL Book value per share

Book value per share at other companies

Pfizer logo
PfizerPFE
$15.72-0.6%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$0.85-22.2%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$0.70+50.9%
Exelixis logo
ExelixisEXEL
$7.24-2.1%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$7.57-31.5%
Incyte logo
IncyteINCY
$27.19+46.9%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Calculated from Nuvalent, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s book value per share?
Nuvalent, Inc. (NUVL) reported book value per share of $14.93 in Q1 2026.
How has Nuvalent, Inc.'s book value per share changed year-over-year?
Nuvalent, Inc.'s book value per share increased by 5.7% year-over-year, from $14.12 to $14.93.
What is the long-term trend for Nuvalent, Inc.'s book value per share?
Over 5 years (2020 to 2025), Nuvalent, Inc.'s book value per share has grown at a 9.5% compound annual growth rate (CAGR), from -$10.92 to $17.17.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.